For research use only. Not for therapeutic Use.
NCDM-32B(Cat No.:I033097)is a novel small molecule compound being researched for its potential applications in cancer therapy. It works by targeting specific signaling pathways involved in cell proliferation, survival, and metastasis. By inhibiting these pathways, NCDM-32B has shown promise in preclinical studies for suppressing tumor growth and reducing the spread of cancer cells. The compound is primarily explored for its ability to interfere with tumor cell metabolism and promote apoptosis, making it a valuable candidate in the development of targeted cancer therapies. Further clinical studies are needed to evaluate its full therapeutic potential.
CAS Number | 1239468-48-4 |
Synonyms | methyl 3-[9-(dimethylamino)nonanoyl-hydroxyamino]propanoate |
Molecular Formula | C15H30N2O4 |
Purity | ≥95% |
IUPAC Name | methyl 3-[9-(dimethylamino)nonanoyl-hydroxyamino]propanoate |
InChI | InChI=1S/C15H30N2O4/c1-16(2)12-9-7-5-4-6-8-10-14(18)17(20)13-11-15(19)21-3/h20H,4-13H2,1-3H3 |
InChIKey | KDYRPQNFCURCQB-UHFFFAOYSA-N |
SMILES | CN(C)CCCCCCCCC(=O)N(CCC(=O)OC)O |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |